Sender Company & Partners’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-40,720
Closed -$176K 49
2021
Q4
$176K Buy
+40,720
New +$176K 0.09% 80